Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Karen L Cheal
Introduction
Karen L Cheal is a notable inventor based in Mountain View, CA (US). She has made significant contributions to the field of therapeutic treatments for inflammatory and autoimmune disorders. Her work focuses on the development of biological markers that can evaluate the efficacy of various drugs.
Latest Patents
Karen holds a patent for "Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders." This innovative patent introduces novel biological markers that indicate the action of anti-inflammatory or immunosuppressive drugs. These markers can be utilized to assess drug efficacy and compare local and systemic drug effects. Additionally, they facilitate the comparison of different drugs, doses, and delivery routes. The biological markers include cell populations, cell surface antigen expression levels, and soluble factor concentrations. Measurement values of these biomarkers have shown significant changes in allergic, atopic asthmatic, and healthy subjects after the administration of prednisone.
Career Highlights
Karen is currently employed at Surromed, Inc., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on the treatment of various inflammatory conditions.
Collaborations
Karen has collaborated with notable colleagues, including Susan Alters and Aaron B Kantor, who contribute to her research endeavors.
Conclusion
Karen L Cheal's innovative work in developing biological markers for therapeutic evaluation represents a significant advancement in the field of medicine. Her contributions are poised to enhance the understanding and treatment of inflammatory and autoimmune disorders.